YAP/TEAD Co-Activator regulated pluripotency and chemoresistance in ovarian cancer Initiated Cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Xia, Yan ^a,b   Zhang, Yin Li ^b   Yu, Chao ^b   Chang, Ting ^c   Fan, Heng Yu ^b  

^a Reproductive Center   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CA 125 ANTIGEN; CISPLATIN; GLYCOGEN SYNTHASE KINASE 3; MULTIDRUG RESISTANCE PROTEIN 1; NESTIN; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TEAD; TRANSCRIPTION FACTOR YAP; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TEAD1 PROTEIN, HUMAN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL ISOLATION; CELL SELF-RENEWAL; CELL SIZE; CELLULAR PARAMETERS; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY CANCER INITIATED CELL; PLURIPOTENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR SPHEROID; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; METABOLISM; NUDE MOUSE; OVARIAN NEOPLASMS; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; P-GLYCOPROTEINS; PHOSPHOPROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84934324759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109575     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288.
3. Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, et al. (2012) Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 18: 869-881.
4. Kulkarni-Datar K, Orsulic S, Foster R, Rueda BR (2013) Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo. Cancer Lett 339: 237-246.
5. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF (2012) Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem 363: 257-268.
6. Lu D, Chen S, Tan X, Li N, Liu C, et al. (2012) Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy. Cancer Res 72: 3451-3456.
7. Zhang S, Balch C, Chan MW, Lai HC, Matei D, et al. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320.
8. McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, et al. (2012) Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A 109: E2939-2948.
9. Chefetz I, Alvero AB, Holmberg JC, Lebowitz N, Craveiro V, et al. (2013) TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence. Cell Cycle 12: 511-521.
10. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, et al. (2009) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28: 209-218.
11. Chen J, Wang J, Chen D, Yang J, Yang C, et al. (2013) Evaluation of characteristics of CD44+ CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. BMC Cell Biol 14: 1-11.
12. Demircan T, Berezikov E (2013) The Hippo pathway regulates stem cells during homeostasis and regeneration of the flatworm Macrostomum lignano. Stem Cells Dev 22: 2174-2185.
13. Leung CY, Zernicka-Goetz M (2013) Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and - independent mechanisms. Nat Commun 4: 2251.
14. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, et al. (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118.
15. Beverdam A, Claxton C, Zhang X, James G, Harvey KF, et al. (2013) Yap controls stem/progenitor cell proliferation in the mouse postnatal epidermis. J Invest Dermatol 133: 1497-1505.
16. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, et al. (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458: 776-779.
17. Konsavage WM Jr, Kyler SL, Rennoll SA, Jin G, Yochum GS (2012) Wnt/betacatenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 287: 11730-11739.
18. Krausova M, Korinek V (2013) Wnt signaling in adult intestinal stem cells and cancer. Cell Signal 26: 570-579.
19. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, et al. (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18: 579-591.
20. Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA, et al. (2014) p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med 20: 265-271.
21. Airiau K, Mahon FX, Josselin M, Jeanneteau M, Belloc F (2013) PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor. Cell Death Dis 4: E827.
22. Judson RN, Tremblay AM, Knopp P, White RB, Urcia R, et al. (2012) The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells. J Cell Sci 125: 6009-6019.
23. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, et al. (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147: 759-772.
24. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
25. Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, et al. (2012) Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum Mol Genet 21: 2054-2067.
26. Mohseni M, Sun J, Lau A, Curtis S, Goldsmith J, et al. (2014) A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway. Nat Cell Biol 16: 108-117.
27. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
28. Fan R, Kim NG, Gumbiner BM (2013) Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositidedependent kinase-1. Proc Natl Acad Sci U S A 110: 2569-2574.
29. Dong A, Gupta A, Pai RK, Tun M, Lowe AW (2011) The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation. J Biol Chem 286: 18301- 18310.
30. Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, et al. (2009) YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 11: 1444-1450.
31. Peng S, Maihle NJ, Huang Y (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29: 2153-2159.
32. Schwede M, Spentzos D, Bentink S, Hofmann O, Haibe-Kains B, et al. (2013) Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis. PLoS One 8: E57799.
33. Ricci F, Bernasconi S, Perego P, Ganzinelli M, Russo G, et al. (2012) Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. Cell Cycle 11: 1966-1976.
34. Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, et al. (2012) Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One 7: E29079.
35. Cao X, Pfaff SL, Gage FH (2008) YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 22: 3320-3334.
36. Tamm C, Bower N, Anneren C (2011) Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 124: 1136-1144.
37. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, et al. (2011) Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 108: E1312-1320.
38. Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, et al. (2013) Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493: 106-110.
39. Nejigane S, Takahashi S, Haramoto Y, Michiue T, Asashima M (2013) Hippo signaling components, Mst1 and Mst2, act as a switch between self-renewal and differentiation in Xenopus hematopoietic and endothelial progenitors. Int J Dev Biol 57: 407-414.
40. Shaw RL, Kohlmaier A, Polesello C, Veelken C, Edgar BA, et al. (2010) The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 137: 4147-4158.
41. Lau AN, Curtis SJ, Fillmore CM, Rowbotham SP, Mohseni M, et al. (2014) Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. EMBO J 33: 468-481.
42. Flores ER, Halder G (2011) Stem cell proliferation in the skin: Alpha-catenin takes over the hippo pathway. Sci Signal 4: Pe34.
43. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
44. Pan WW, Yi FP, Cao LX, Liu XM, Shen ZF, et al. (2013) DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage. Gene 526: 287-294.
45. Pan WW, Zhou JJ, Liu XM, Xu Y, Guo LJ, et al. (2013) Death domainassociated protein DAXX promotes ovarian cancer development and chemoresistance. J Biol Chem 288: 13620-13630.